Quantcast

Latest LoneStar Heart Inc. Stories

2014-05-05 08:29:16

Six-month Outcomes of AUGMENT-HF Multicenter Study to Be Presented by Yearend LAGUNA HILLS, Calif., May 5, 2014 /PRNewswire/ -- LoneStar Heart, Inc. today announced that it completed the patient recruitment phase of the company's AUGMENT-HF controlled randomized trial of Algisyl-LVR hydrogel implant, its lead product for the treatment of advanced heart failure (HF). LoneStar Heart expects to present six-month outcomes by yearend. The AUGMENT-HF clinical trial is being conducted at...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'